Related Experiment Videos
Decreased erythrocyte deformability in Behçet's disease
Oğuz Usküdar1, Ayşen Erdem, Halûk Demiroğlu
1Department of Hematology, Hacettepe University Faculty of Medicine, Ankara, Turkey. ouskudar@hotmail.com
Clinical Hemorheology and Microcirculation
|September 10, 2005
Summary
Erythrocyte deformability (ED) is significantly reduced in active Behçet's disease (BD) patients, contributing to their increased thrombotic risk. Restoring ED may be a key therapeutic target for managing BD complications.
Area of Science:
- Rheology
- Hematology
- Immunology
Background:
- Behçet's disease (BD) is a chronic systemic vasculitis characterized by a high thrombotic tendency.
- Hemorheological changes, particularly erythrocyte deformability (ED), are critical determinants of microcirculation and blood viscosity but remain unstudied in BD.
Purpose of the Study:
- To investigate erythrocyte deformability (ED) in active Behçet's disease (BD) patients.
- To explore the potential role of altered ED in the thrombotic complications associated with BD.
Main Methods:
- Erythrocyte deformability (ED) was measured using the filtration method.
- A cohort of 13 active BD patients was compared with 13 age-, sex-, weight-, smoking habit-, and blood pressure-matched healthy controls.
Main Results:
- Active BD patients exhibited significantly decreased erythrocyte deformability (ED) compared to healthy controls (median DI: 3.19 vs. 2.08, p<0.001).
- Reduced ED may contribute to the heightened thrombotic tendency observed in Behçet's disease.
Conclusions:
- Impaired erythrocyte deformability (ED) is a novel finding in active Behçet's disease (BD) and may play a crucial role in its thrombotic complications.
- Therapeutic strategies aimed at increasing ED, such as pentoxifylline, could be beneficial in treating BD by correcting this hemorheological abnormality.